Literature DB >> 15654821

Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.

M Chiara1, E Menegatti, D Di Simone, A Davit, D Bellis, D Sferch, G De Rosa, O Giachino, L M Sena, D Roccatello.   

Abstract

The response of mesangial cells to a phlogistic challenge includes cell proliferation and mesangial matrix expansion. Cell proliferation is a highly regulated process which includes enhancing factors such as cyclins, cyclin dependent kinases, and inhibitory proteins, such as p27(kip1). The aim of the study was to evaluate the effects of Mycophenolate mofetil (MMF), and roscovitine (R), on the cell cycle regulatory system when administered in the florid phase of the experimental model of mesangial proliferative nephritis induced by the anti Thy-1 antigen monoclonal antibody. Three days after nephritis induction, different groups were given MMF and R. Rats treated with MMF or R showed a slight decrease in mesangial proliferation and matrix expansion. Samples of cortical tissue were tested by 'real time' RT-PCR in order to study gene expression of cyclins B, D1, D2, D3, E, and the cyclin inhibitor p27(kip1). Localization of mRNA was evaluated by in situ hybridization. Real time RT-PCR analysis showed a significant decrease in cyclins B, D1, D2, and D3 in rats treated with either MMF or R as compared to controls. Both MMF and R treatment induced a significant increase in p27(kip1) mRNA expression. In situ hybridization showed a mesangial-endothelial expression pattern in glomeruli. The number of labelled cells per glomerulus, the number of positive glomeruli in each examined slide as well as cyclin D2 and D3 signal intensity was significantly lower in rats treated with MMF or R as compared to controls, whereas MMF or R treatment up-regulated p27(kip1) mRNA expression. Immunohistochemical evaluation of p27(kip1) aimed to examine the influence of MMF or R on protein expression confirmed up-regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654821      PMCID: PMC1809292          DOI: 10.1111/j.1365-2249.2004.02684.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  ATP-site directed inhibitors of cyclin-dependent kinases.

Authors:  N Gray; L Détivaud; C Doerig; L Meijer
Journal:  Curr Med Chem       Date:  1999-09       Impact factor: 4.530

Review 2.  Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.

Authors:  S J Shankland; G Wolf
Journal:  Am J Physiol Renal Physiol       Date:  2000-04

3.  Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.

Authors:  T Hara; T Kamura; K Nakayama; K Oshikawa; S Hatakeyama; K Nakayama
Journal:  J Biol Chem       Date:  2001-10-26       Impact factor: 5.157

Review 4.  Mycophenolate mofetil: implications for the treatment of glomerular disease.

Authors:  C Badid; A Desmouliere; M Laville
Journal:  Nephrol Dial Transplant       Date:  2001-09       Impact factor: 5.992

5.  Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy.

Authors:  Momir Polenakovic; Ladislava Grcevska; Sonja Dzikova
Journal:  Nephrol Dial Transplant       Date:  2003-06       Impact factor: 5.992

6.  Retinoid receptor-specific agonists alleviate experimental glomerulonephritis.

Authors:  Ingo Lehrke; Matthias Schaier; Kerstin Schade; Christian Morath; Ruediger Waldherr; Eberhard Ritz; Juergen Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2002-04

Review 7.  Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies.

Authors:  Roberto Zatz; Irene Lourdes Noronha; Clarice Kazue Fujihara
Journal:  Am J Physiol Renal Physiol       Date:  2002-12

8.  Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.

Authors:  T M Chan; F K Li; C S Tang; R W Wong; G X Fang; Y L Ji; C S Lau; A K Wong; M K Tong; K W Chan; K N Lai
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

9.  Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat.

Authors:  T Yamamoto; C B Wilson
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

Review 10.  Mycophenolate mofetil in solid-organ transplantation.

Authors:  Titte R Srinivas; Bruce Kaplan; Herwig Ulf Meier-Kriesche
Journal:  Expert Opin Pharmacother       Date:  2003-12       Impact factor: 3.889

View more
  6 in total

1.  In rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-alpha.

Authors:  Hong-Wei Chang; Vin-Cent Wu; Kwan-Dun Wu; Hong-Yu Huang; Bor-Shen Hsieh; Yung-Ming Chen
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses.

Authors:  Tanya A Rege; James S Hagood
Journal:  Biochim Biophys Acta       Date:  2006-08-18

Review 3.  Roscovitine in cancer and other diseases.

Authors:  Jonas Cicenas; Karthik Kalyan; Aleksandras Sorokinas; Edvinas Stankunas; Josh Levy; Ingrida Meskinyte; Vaidotas Stankevicius; Algirdas Kaupinis; Mindaugas Valius
Journal:  Ann Transl Med       Date:  2015-06

Review 4.  Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.

Authors:  Agnes Hackl; Rasmus Ehren; Lutz Thorsten Weber
Journal:  Pediatr Nephrol       Date:  2016-06-16       Impact factor: 3.714

5.  A Rho-kinase inhibitor, fasudil, attenuates progressive glomerulosclerosis induced by daunorubicin in rats.

Authors:  Bingqing Deng; Xiao Yang; Zhonghua Zhu; Chun Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

Review 6.  Roles of the Skp2/p27 axis in the progression of chronic nephropathy.

Authors:  Sayuri Suzuki; Naro Ohashi; Masatoshi Kitagawa
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.